Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
Should optical coherence tomography be used to manage patients with multiple sclerosis?
Ambulation and multiple sclerosis.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Variability in the CIITA gene interacts with HLA in multiple sclerosis.
Alexithymia in Neurological Disease: A Review.
Advances in the treatment of relapsing - Remitting multiple sclerosis.
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
Self-report versus performance measure in gauging level of function with multiple sclerosis.
TREK-King the Blood-Brain-Barrier.
Validity of Maximal Exercise Testing in Patients With Low to Moderate Multiple Sclerosis.
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis.
IL1-β expression in multiple sclerosis.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »